Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest (RESTORE)

NCT05851391 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT05851391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05851391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest (RESTORE)
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Recruiting
Start date
August 7, 2023
Completion date
April 30, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anoxia-ischemia, cerebral, anoxic-ischemic encephalopathy, heart arrest, hypoxia-ischemia, brain, refractory status epilepticus, seizures, status epilepticus